SPIRONOLACTONE Side Effects

7022052-5 | Neutropenia
on Sep 17, 2010 Female patient from DENMARK , 81 years of age, was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia. Spironolactone dosage: 25 Mg. During the same period patient was treated with DALTEPARIN SODIUM (View Dalteparin Sodium Review and Dalteparin Sodium Label ), DOSULEPIN (View Dosulepin Review and Dosulepin Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ).

7017550-4 | Alopecia, Fatigue, Pruritus, Rash, Somnolence
Patient was taking Spironolactone (View Usage). Patient had the following side effects: alopecia, fatigue, pruritus, rash (What is rash?), somnolence on Aug 24, 2009 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with blood pressure increased and. Spironolactone dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

7017418-3 | Renal Failure Acute
Adverse event was reported on May 26, 2010 by a Female patient taking Spironolactone (View Usage) (Dosage: 25 Mg, Qd) was diagnosed with hypertension, stress urinary incontinence, vascular dementia, extrapyramidal disorder, initial insomnia, prophylaxis against gastrointestinal ulcer and. Location: GERMANY , 84 years of age, weighting 158.7 lb, After Spironolactone was administered, patient had the following side effects: renal failure acute. During the same period patient was treated with XIPAMID (10 Mg, Qd) (View Xipamid Review and Xipamid Label ), TORASEMID (5 Mg, Qd) (View Torasemid Review and Torasemid Label ), RAMIPRIL (2.5 Mg, Qd) (View Ramipril Review and Ramipril Label ), MICTONORM (15 Mg, Qd) (View Mictonorm Review and Mictonorm Label ), MELPERON (25 Mg, Qd) (View Melperon Review and Melperon Label ), AKINETON (2 Mg, Qd) (View Akineton Review and Akineton Label ), ZOLPIDEM AL 5 MG (5 Mg, Qd) (View Zolpidem Al 5 Mg Review and Zolpidem Al 5 Mg Label ), PANTOPRAZOL 40 MG (40 Mg, Qd) (View Pantoprazol 40 Mg Review and Pantoprazol 40 Mg Label ). Patient was hospitalized.

7015319-8 | Hyperkalaemia
on Sep 24, 2010 Male patient from UNITED STATES , 67 years of age, weighting 158.7 lb, was diagnosed with cardiac failure congestive and was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia. Spironolactone dosage: 50 Mg Every Day Po. Patient was hospitalized.


7013593-5 | Asthenia, Dehydration, Hyperkalaemia
on Sep 15, 2010 Female patient from SPAIN , 82 years of age, was treated with Spironolactone (View Usage). Patient had the following side effects: asthenia, dehydration, hyperkalaemia. Spironolactone dosage: 100 Mg/day. During the same period patient was treated with ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ). Patient was hospitalized.

7006113-2 | Decreased Activity, Discomfort, Oedema
Patient was taking Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: decreased activity, discomfort, oedema on Sep 10, 2010 from UNITED STATES Additional patient health information: Female patient , 89 years of age, was diagnosed with fluid retention and. Spironolactone dosage: Unk. During the same period patient was treated with FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ).

7003400-9 | Stomatitis
Adverse event was reported on Sep 07, 2010 by a Female patient taking Spironolactone (View Usage) (Dosage: 50 Mg, 1x/day) was diagnosed with hypertension and. Location: UNITED STATES , weighting 179.9 lb, Patient experienced the following unwanted or unexpected effects: stomatitis. During the same period patient was treated with VITAMIN B 12 (1000 Ug, 1x/day) (View Vitamin B-12 Review and Vitamin B-12 Label ), ONE A DAY (Unk) (View One-a-day Review and One-a-day Label ).

7001735-7 | Bradycardia, Dyspnoea, Hyperkalaemia, Loss Of Consciousness, Malaise
on Sep 17, 2010 Male patient from GERMANY , 76 years of age, weighting 160.9 lb, was diagnosed with oedema, hypertension, cardiovascular event prophylaxis, hypercholesterolaemia, gastrooesophageal reflux prophylaxis and was treated with Spironolactone (View Usage). Patient had the following side effects: bradycardia, dyspnoea, hyperkalaemia, loss of consciousness, malaise. Spironolactone dosage: 12.5 Mg, Qd. During the same period patient was treated with BISOPROLOL (2.5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), ACETYLSALICYLIC ACID (100 Mg, Qd) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ATACAND (8 Mg, Qd) (View Atacand Review and Atacand Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ), EZETIMIBE/SIMVASTATIN (10 Mg Ezetimibe, 20 Mg Simvastatin) (View Ezetimibe/simvastatin Review and Ezetimibe/simvastatin Label ), OMEPRAZOLE (20 Mg, Qd) (View Omeprazole Review and Omeprazole Label ), TORASEMIDE (10 Mg, Qd) (View Torasemide Review and Torasemide Label ). Patient was hospitalized.

6988761-9 | Gastrointestinal Haemorrhage
on Sep 03, 2010 Male patient from GERMANY , 58 years of age, weighting 233.7 lb, was diagnosed with oedema, prophylaxis, osteoarthritis (What is osteoarthritis?), type 2 diabetes mellitus, hyperuricaemia, hypertension, chronic obstructive pulmonary disease and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: gastrointestinal haemorrhage. Spironolactone dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), METFORMIN (View Metformin Review and Metformin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), RASILEZ /01763601/ (View Rasilez /01763601/ Review and Rasilez /01763601/ Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), CORDINATE (View Cordinate Review and Cordinate Label ), BYETTA (View Byetta Review and Byetta Label ). Patient was hospitalized.

6976336-7 | Acute Prerenal Failure, Dehydration, Hypoglycaemia
Patient was taking Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, dehydration, hypoglycaemia on Sep 01, 2010 from JAPAN Additional patient health information: Male patient , 50 years of age, weighting 160.9 lb, . Spironolactone dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), VERAPAMIL HYDROCHLORIDE (View Verapamil Hydrochloride Review and Verapamil Hydrochloride Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), METHIMAZOLE (View Methimazole Review and Methimazole Label ). Patient was hospitalized.

6971848-4 | Blood Potassium Increased
Adverse event was reported on Sep 08, 2010 by a Male patient taking Spironolactone (View Usage) (Dosage: 25 Mg Every Day Po) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 63 years of age, weighting 251.3 lb, Patient had the following side effects: blood potassium increased. Patient was hospitalized.

6967630-4 | Acne Cystic, Confusional State, Tongue Cyst
on Aug 19, 2010 Female patient from UNITED KINGDOM , 32 years of age, was diagnosed with polycystic ovaries and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: acne cystic, confusional state, tongue cyst. Spironolactone dosage: 50 Mg;bid.

6964709-8 | Abdominal Discomfort, Blood Potassium Increased, Blood Pressure Decreased
on Aug 24, 2010 Male patient from SWEDEN , 90 years of age, was diagnosed with cardiac failure and was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, blood potassium increased, blood pressure decreased. Spironolactone dosage: 25 Mg, 1x/day. During the same period patient was treated with DUROFERON (100 Mg, 1x/day) (View Duroferon Review and Duroferon Label ), ASPIRIN (75 Mg, 1x/day) (View Aspirin Review and Aspirin Label ), IMPUGAN (40 Mg, 2x/day) (View Impugan Review and Impugan Label ), ENALAPRIL (2.5 Mg, 2x/day) (View Enalapril Review and Enalapril Label ), OMEPRAZOLE (20 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ), FOLACIN (5 Mg, 1x/day) (View Folacin Review and Folacin Label ).

6962819-2 | Acute Prerenal Failure, Bradycardia, Cardiogenic Shock, Hyperkalaemia
Patient was taking Spironolactone (View Usage). Patient had the following side effects: acute prerenal failure, bradycardia, cardiogenic shock, hyperkalaemia on Aug 23, 2010 from NORWAY Additional patient health information: Male patient , 75 years of age, was diagnosed with cardiac failure and. Spironolactone dosage: 25 Mg, Daily. During the same period patient was treated with RAMIPRIL (10 Mg, Daily) (View Ramipril Review and Ramipril Label ), METOPROLOL (100 Mg, Daily) (View Metoprolol Review and Metoprolol Label ), BUMETANIDE (1.5 Mg, Daily) (View Bumetanide Review and Bumetanide Label ), DIGITOXIN (50 Ug, Daily) (View Digitoxin Review and Digitoxin Label ). Patient was hospitalized.

6960320-3 | Acne Cystic, Confusional State
Adverse event was reported on Aug 13, 2010 by a Female patient taking Spironolactone (View Usage) (Dosage: 50 Mg; Bid) was diagnosed with polycystic ovaries and. Location: UNITED KINGDOM , 32 years of age, After Spironolactone was administered, patient had the following side effects: acne cystic, confusional state. During the same period patient was treated with CON MEDS (View Con Meds Review and Con Meds Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ).

6938839-0 | Blood Potassium Increased, Myocardial Infarction, Personality Change
on Aug 13, 2010 Female patient from SWEDEN , 54 years of age, was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, myocardial infarction, personality change. Spironolactone dosage: 25 Mg, Unk. During the same period patient was treated with RAMIPRIL (1.25 Mg, Unk) (View Ramipril Review and Ramipril Label ), POTASSIUM CHLORIDE (750 Mg, 2x/day) (View Potassium Chloride Review and Potassium Chloride Label ), DICLOFENAC (Unk) (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

6933255-X | Bradycardia, Cardiogenic Shock, Hyperkalaemia, Renal Failure Acute
on Aug 09, 2010 Male patient from NORWAY , 75 years of age, was treated with Spironolactone (View Usage). Patient had the following side effects: bradycardia, cardiogenic shock, hyperkalaemia, renal failure acute. Spironolactone dosage: 25 Mg, Daily. During the same period patient was treated with RAMIPRIL (10 Mg, Daily) (View Ramipril Review and Ramipril Label ), METOPROLOL (100 Mg, Daily) (View Metoprolol Review and Metoprolol Label ), BUMETANIDE (1.5 Mg, Daily) (View Bumetanide Review and Bumetanide Label ), DIGITOXIN (50 Ug, Daily) (View Digitoxin Review and Digitoxin Label ). Patient was hospitalized.

6930336-1 | Bradycardia, Cardiogenic Shock, Hyperkalaemia, Renal Failure Acute
Patient was taking Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: bradycardia, cardiogenic shock, hyperkalaemia, renal failure acute on Aug 06, 2010 from NORWAY Additional patient health information: Male patient , 75 years of age, . Spironolactone dosage: 25 Mg, Daily. During the same period patient was treated with RAMIPRIL (10 Mg, Daily) (View Ramipril Review and Ramipril Label ), METOPROLOL (100 Mg, Daily) (View Metoprolol Review and Metoprolol Label ), BUMETANIDE (1.5 Mg, Daily) (View Bumetanide Review and Bumetanide Label ), DIGITOXIN (50 Ug, Daily) (View Digitoxin Review and Digitoxin Label ). Patient was hospitalized.

6914924-4 | Dehydration, Dizziness, Renal Failure Acute
Adverse event was reported on Aug 04, 2010 by a Male patient taking Spironolactone (View Usage) (Dosage: ) . Location: UNITED STATES , 59 years of age, Patient experienced the following unwanted or unexpected effects: dehydration, dizziness (What is dizziness?), renal failure acute. Patient was hospitalized.

6909723-3 | Cerebral Haemorrhage
on Jul 23, 2010 Male patient from GERMANY , 63 years of age, weighting 158.7 lb, was diagnosed with hepatic neoplasm malignant and was treated with Spironolactone (View Usage). Patient had the following side effects: cerebral haemorrhage. Spironolactone dosage: . During the same period patient was treated with FURORESE (View Furorese Review and Furorese Label ), SORAFENIB (View Sorafenib Review and Sorafenib Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), PROTAPHANE (6 E Z.n.) (View Protaphane Review and Protaphane Label ), ACTRAPID (10-8-6 E) (View Actrapid Review and Actrapid Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), MAGNESIUM VERLA /00648601/ (Daily Dose: 2 Df Dosage Form Every Days) (View Magnesium Verla /00648601/ Review and Magnesium Verla /00648601/ Label ), KOCHSALZ LOESUNG (Daily Dose: 8 Df Dosage Form Every Days) (View Kochsalz-loesung Review and Kochsalz-loesung Label ).

6894512-9 | Bradycardia, Cardiogenic Shock, Hyperkalaemia, Renal Failure Acute
on Jul 19, 2010 Male patient from NORWAY , 75 years of age, was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: bradycardia, cardiogenic shock, hyperkalaemia, renal failure acute. Spironolactone dosage: 25 Mg, Daily. During the same period patient was treated with RAMIPRIL (10 Mg, Daily) (View Ramipril Review and Ramipril Label ), BUMETANIDE (1.5 Mg, Daily) (View Bumetanide Review and Bumetanide Label ), METOPROLOL (100 Mg, Daily) (View Metoprolol Review and Metoprolol Label ), DIGITOXIN (50 Ug, Daily) (View Digitoxin Review and Digitoxin Label ). Patient was hospitalized.

6874910-X | Blood Potassium Increased, Bone Pain, Limb Discomfort, Muscle Spasms
Patient was taking Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, bone pain, limb discomfort, muscle spasms on Mar 14, 2009 from UNITED STATES Additional patient health information: Female patient , 73 years of age, weighting 147.7 lb, was diagnosed with hypertension and. Spironolactone dosage: 25 Mg, 1x/day. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ).

6874909-3 | Constipation, Cyst, Menstruation Irregular, Rash Macular
Adverse event was reported on Sep 19, 2008 by a Female patient taking Spironolactone (View Usage) (Dosage: Daily Every Day) was diagnosed with acne (What is acne?) and. Location: UNITED STATES , 36 years of age, weighting 122.4 lb, Patient had the following side effects: constipation (What is constipation?), cyst, menstruation irregular, rash macular.

6874908-1 | Agranulocytosis, Diarrhoea, Hypotension, Nausea, Pyrexia
on Apr 14, 2008 Female patient from UNITED STATES , 32 years of age, was diagnosed with acne (What is acne?) and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: agranulocytosis, diarrhoea, hypotension, nausea (What is nausea?), pyrexia. Spironolactone dosage: 100 Mg, 1x/day, Oral. Patient was hospitalized.

6874907-X | Hyperkalaemia
on Mar 29, 2010 Male patient from UNITED STATES , 70 years of age, was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia. Spironolactone dosage: . Patient was hospitalized.

6860247-1 | Atrial Fibrillation, Blood Glucose Increased, Blood Pressure Systolic Increased, Body Temperature Increased, Flatulence, Hyperkalaemia
Patient was taking Spironolactone (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood glucose increased, blood pressure systolic increased, body temperature increased, flatulence, hyperkalaemia on Jul 19, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 261.9 lb, was diagnosed with hypertension and. Spironolactone dosage: 50 Mg Every Day Po. During the same period patient was treated with LISINOPRIL (10 Mg Every Day Po) (View Lisinopril Review and Lisinopril Label ).

6856479-9 | Haemodialysis, Hyperkalaemia
Adverse event was reported on Jul 16, 2010 by a Male patient taking Spironolactone (View Usage) (Dosage: 12.5 Mg Bid Po) was diagnosed with ascites, hypertension and. Location: UNITED STATES , 54 years of age, weighting 182.1 lb, After Spironolactone was administered, patient had the following side effects: haemodialysis, hyperkalaemia. During the same period patient was treated with LISINOPRIL (10 Mg Every Day Po) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6848609-X | Bradycardia, Cardiogenic Shock, Hyperkalaemia, Renal Failure Acute
on Jul 05, 2010 Male patient from NORWAY , 75 years of age, was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiogenic shock, hyperkalaemia, renal failure acute. Spironolactone dosage: 25 Mg, Daily. During the same period patient was treated with RAMIPRIL (10 Mg, Daily) (View Ramipril Review and Ramipril Label ), BUMETANIDE (1.5 Mg, Daily) (View Bumetanide Review and Bumetanide Label ), DIGITOXIN (50 Ug, Daily) (View Digitoxin Review and Digitoxin Label ), METOPROLOL (100 Mg, Daily) (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

6835725-1 | Agitation, Hypersensitivity, Psychomotor Hyperactivity
on Jul 01, 2010 Female patient from UNITED STATES , weighting 216.0 lb, was diagnosed with hypertension and was treated with Spironolactone (View Usage). Patient had the following side effects: agitation, hypersensitivity, psychomotor hyperactivity. Spironolactone dosage: 12.5 Mg, Daily. During the same period patient was treated with ADVAIR DISKUS 100/50 (Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6826097-7 | Blood Potassium Decreased, Blood Sodium Decreased, Convulsion, Dehydration, Photosensitivity Reaction
Patient was taking Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: blood potassium decreased, blood sodium decreased, convulsion, dehydration, photosensitivity reaction on Jul 08, 2010 from UNITED STATES Additional patient health information: Male patient , 18 years of age, . Spironolactone dosage: . Patient was hospitalized.

6822838-3 | Rash Maculo-papular, Rash Pruritic
Adverse event was reported on Jul 07, 2010 by a Male patient taking Spironolactone (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: UNITED STATES , 66 years of age, weighting 250.0 lb, Patient experienced the following unwanted or unexpected effects: rash maculo-papular, rash pruritic.

6821776-X | Photosensitivity Reaction
on Jun 23, 2010 Male patient from GERMANY , 60 years of age, weighting 238.1 lb, was diagnosed with oedema peripheral, hyperuricaemia and was treated with Spironolactone (View Usage). Patient had the following side effects: photosensitivity reaction. Spironolactone dosage: Daily Dose: 1 Df Dosage Form Every Days. During the same period patient was treated with ALLOPURINOL (Daily Dose: 0.5 Df Dosage Form Every Days) (View Allopurinol Review and Allopurinol Label ), HUMALOG (12-8-10 Ie/day) (View Humalog Review and Humalog Label ), ASPIRIN (Daily Dose: 1 Df Dosage Form Every Days) (View Aspirin Review and Aspirin Label ), FUROSEMID (Daily Dose: 2 Df Dosage Form Every Days) (View Furosemid Review and Furosemid Label ), NITRENDIPIN (Daily Dose: 1 Df Dosage Form Every Days) (View Nitrendipin Review and Nitrendipin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6821775-8 | Photosensitivity Reaction
on Jun 23, 2010 Male patient from GERMANY , 60 years of age, weighting 238.1 lb, was diagnosed with oedema peripheral, hyperuricaemia and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: photosensitivity reaction. Spironolactone dosage: Daily Dose: 1 Df Dosage Form Every Days. During the same period patient was treated with ALLOPURINOL (Daily Dose: 0.5 Df Dosage Form Every Days) (View Allopurinol Review and Allopurinol Label ), HUMALOG (12-8-10 Ie/day) (View Humalog Review and Humalog Label ), ASPIRIN (Daily Dose: 1 Df Dosage Form Every Days) (View Aspirin Review and Aspirin Label ), FUROSEMID (Daily Dose: 2 Df Dosage Form Every Days) (View Furosemid Review and Furosemid Label ), NITRENDIPIN (Daily Dose: 1 Df Dosage Form Every Days) (View Nitrendipin Review and Nitrendipin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

6810533-6 | Renal Failure Acute
Patient was taking Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute on Jun 18, 2010 from GERMANY Additional patient health information: Female patient , 78 years of age, weighting 176.4 lb, was diagnosed with hypertension, hyperlipidaemia, atrial fibrillation (What is atrial fibrillation?), gastritis haemorrhagic and. Spironolactone dosage: . During the same period patient was treated with DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), DIOVAN HCT (1df= 160mg Valsartan + 25mg Hct) (View Diovan Hct Review and Diovan Hct Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), EZETIMIBE W/SIMVASTATIN (1df= 10mg Ezetimib + 20mg Simvastatin) (View Ezetimibe W/simvastatin Review and Ezetimibe W/simvastatin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6810532-4 | Renal Failure Acute
Adverse event was reported on Jun 18, 2010 by a Female patient taking Spironolactone (View Usage) (Dosage: ) was diagnosed with hypertension, hyperlipidaemia, atrial fibrillation (What is atrial fibrillation?), gastritis haemorrhagic and. Location: GERMANY , 78 years of age, weighting 176.4 lb, Patient had the following side effects: renal failure acute. During the same period patient was treated with DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), DIOVAN HCT (1df= 160mg Valsartan + 25mg Hct) (View Diovan Hct Review and Diovan Hct Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), EZETIMIBE W/SIMVASTATIN (1df= 10mg Ezetimib + 20mg Simvastatin) (View Ezetimibe W/simvastatin Review and Ezetimibe W/simvastatin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6809708-1 | Somnambulism
on Apr 02, 2007 Male patient from UNITED STATES , 84 years of age, weighting 210.0 lb, was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: somnambulism. Spironolactone dosage: . During the same period patient was treated with PROCARDIA XL (View Procardia Xl Review and Procardia Xl Label ), LASIX (View Lasix Review and Lasix Label ), TAPAZOL (View Tapazol Review and Tapazol Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

6808153-2 | Blood Potassium Increased, Bone Pain, Limb Discomfort, Muscle Spasms
on Mar 14, 2009 Female patient from UNITED STATES , weighting 147.7 lb, was diagnosed with hypertension and was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, bone pain, limb discomfort, muscle spasms. Spironolactone dosage: 25 Mg, 1x/day. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ).

6807618-7 | Asthenia, Gynaecomastia, Nausea, Pain
Patient was taking Spironolactone (View Usage). Patient had the following side effects: asthenia, gynaecomastia, nausea (What is nausea?), pain (What is pain?) on Oct 28, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 190.5 lb, was diagnosed with muscle disorder (What is muscle disorder?), dyspepsia and. Spironolactone dosage: . During the same period patient was treated with RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ), POTASSIUM (View Potassium Review and Potassium Label ).

6807442-5 | Constipation, Cyst, Menstruation Irregular, Rash Macular
Adverse event was reported on Sep 19, 2008 by a Female patient taking Spironolactone (View Usage) (Dosage: Daily Every Day) was diagnosed with acne (What is acne?) and. Location: UNITED STATES , weighting 122.3 lb, After Spironolactone was administered, patient had the following side effects: constipation (What is constipation?), cyst, menstruation irregular, rash macular.

6807305-5 | Diarrhoea, Dizziness, Headache, Nausea, Palpitations
on Sep 02, 2008 Female patient from UNITED STATES , weighting 300.6 lb, was diagnosed with hyperaldosteronism and was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, dizziness (What is dizziness?), headache (What is headache?), nausea (What is nausea?), palpitations. Spironolactone dosage: Every Day. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), XANAX (View Xanax Review and Xanax Label ).

6806693-3 | Agranulocytosis, Diarrhoea, Hypotension, Nausea, Pyrexia
on Apr 14, 2008 Female patient from UNITED STATES , 32 years of age, was diagnosed with acne (What is acne?) and was treated with Spironolactone (View Usage). Patient had the following side effects: agranulocytosis, diarrhoea, hypotension, nausea (What is nausea?), pyrexia. Spironolactone dosage: . Patient was hospitalized.

6806351-5 | Urine Output Increased
Patient was taking Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: urine output increased on Feb 04, 2008 from UNITED STATES Additional patient health information: Male patient , 86 years of age, was diagnosed with swelling and. Spironolactone dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ).

6806163-2 | Vision Blurred
Adverse event was reported on Dec 12, 2007 by a Male patient taking Spironolactone (View Usage) (Dosage: ) was diagnosed with oedema peripheral, hypertension and. Location: UNITED STATES , weighting 225.5 lb, Patient experienced the following unwanted or unexpected effects: vision blurred. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6805788-8 | Hallucination, Hyperkalaemia
on Jun 14, 2010 Female patient from GERMANY , 89 years of age, weighting 154.3 lb, was diagnosed with hypertension, tachyarrhythmia, sleep disorder (What is sleep disorder?), depression (What is depression?), dyspepsia and was treated with Spironolactone (View Usage). Patient had the following side effects: hallucination, hyperkalaemia. Spironolactone dosage: . During the same period patient was treated with DIGITOXIN (View Digitoxin Review and Digitoxin Label ), RASILEZ /01763601/ (View Rasilez /01763601/ Review and Rasilez /01763601/ Label ), EXFORGE (View Exforge Review and Exforge Label ), BIKALM (View Bikalm Review and Bikalm Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), METOPROLOL (Stationar Beloc Zok Gleich 1x1tbl.) (View Metoprolol Review and Metoprolol Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6805787-6 | Hallucination, Hyperkalaemia
on Jun 14, 2010 Female patient from GERMANY , 89 years of age, weighting 154.3 lb, was diagnosed with hypertension, tachyarrhythmia, sleep disorder (What is sleep disorder?), depression (What is depression?), dyspepsia and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: hallucination, hyperkalaemia. Spironolactone dosage: . During the same period patient was treated with DIGITOXIN (View Digitoxin Review and Digitoxin Label ), RASILEZ /01763601/ (View Rasilez /01763601/ Review and Rasilez /01763601/ Label ), EXFORGE (View Exforge Review and Exforge Label ), BIKALM (View Bikalm Review and Bikalm Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), METOPROLOL (Stationar Beloc Zok Gleich 1x1tbl.) (View Metoprolol Review and Metoprolol Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6802084-X | Alopecia
Patient was taking Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia on May 29, 2007 from UNITED STATES Additional patient health information: Female patient , 77 years of age, . Spironolactone dosage: .

6802032-2 | Insomnia, Rash
Adverse event was reported on Oct 24, 2007 by a Female patient taking Spironolactone (View Usage) (Dosage: ) was diagnosed with blood pressure (What is blood pressure?) and. Location: UNITED STATES , weighting 185.2 lb, Patient had the following side effects: insomnia, rash (What is rash?). During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ).

6796309-7 | Product Substitution Issue, Weight Increased
on Jun 24, 2010 Female patient from UNITED STATES , 46 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: product substitution issue, weight increased. Spironolactone dosage: 25mg Bid Po.

6794553-6 | Blood Potassium Increased, Ill-defined Disorder
on Jun 15, 2010 Female patient from SWEDEN , 54 years of age, was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, ill-defined disorder. Spironolactone dosage: 25 Mg, Unk. During the same period patient was treated with RAMIPRIL (1.25 Mg, Unk) (View Ramipril Review and Ramipril Label ), POTASSIUM CHLORIDE (750 Mg, 2x/day) (View Potassium Chloride Review and Potassium Chloride Label ), DICLOFENAC (Unk) (View Diclofenac Review and Diclofenac Label ).

6776787-X | Blood Amylase Increased, Hepatic Steatosis, Hepatitis Acute, Renal Cyst, Serum Ferritin Increased
Patient was taking Spironolactone (View Usage). Patient had the following side effects: blood amylase increased, hepatic steatosis, hepatitis acute, renal cyst, serum ferritin increased on Jun 17, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 281.5 lb, . Spironolactone dosage: . During the same period patient was treated with NOVOLOG (View Novolog Review and Novolog Label ), KAYEXALATE (View Kayexalate Review and Kayexalate Label ), CATAPRES (View Catapres Review and Catapres Label ), LANTUS (View Lantus Review and Lantus Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), ULTRAM (View Ultram Review and Ultram Label ), ZESTRIL (View Zestril Review and Zestril Label ).